The new administration has hardly hidden its disdain for regulation and disinterest in regulatory oversight. Nonetheless, year-to-date activity by federal regulators signals that agencies have no intention of letting up on their policing of the supplement industry. By mid-July 2017, the U.S. Food and Drug Administration (FDA) had issued nearly the same number of warning letters to supplement companies as it had for all of 2016. The warning letters cite numerous claim, labeling, branding and current good manufacturing practices (CGMP) violations.

Read the article here.